Smokers seem less likely than non-smokers to fall ill with covid-19

@ TheEconomist.com, May 2 edition (can see free if registered--5 free articles per month)

A quarter of French adults smoke. Many people were surprised, therefore, when researchers reported late in April that only 5% of 482 covid-19 patients who came to the Pitié-Salpêtrière hospital in Paris between February 28th and April 9th were daily smokers. The ratios of smokers to non-smokers in earlier tallies at hospitals in America, China and elsewhere in France varied. But all revealed habitual smokers to be significantly underrepresented among those requiring hospital treatment for the illness. Smokers, the authors of the report wrote, “are much less likely” to suffer severely from sars-cov-2, the virus that causes covid-19. Rarely, they added, is such a result seen in medicine.

Smokers are almost certainly not protected from initial infection by sars-cov-2. In fact, because they first handle and then puff on cigarettes, they may be especially susceptible—for transmission often takes place through the mouth’s mucous membranes. What seems to be happening is that infected smokers are less likely to develop symptoms, or, if they do develop them, are more likely than non-smokers to have symptoms which are mild. That means they are more likely to stay home and not to show up in hospital statistics.

All this suggests that something in tobacco smoke is having a protective effect. The best guess is that the something in question is nicotine. News of this hypothesis has spread like wildfire. To stop a run on nicotine chemically extracted from tobacco, which is taken in one form or another by many smokers who are trying to quit the habit, France’s health ministry suspended online sales of the substance on April 24th. Purchases from pharmacies were limited to a month’s supply per person. With encouragement from the health minister, the organisations behind the Pitié-Salpêtrière study, which include the Pasteur Institute and the Sorbonne, are preparing trials. The plan is to offer nicotine patches to covid-19 patients, front-line workers and ordinary citizens. How they fare will be compared with control groups given a placebo.

Nicotine is not thought to attack sars-cov-2 directly. 

It may, however, play an indirect role that involves a cell-membrane protein called ace2, to which the virus attaches itself in order to gain access to a cell. Some researchers suspect that nicotine binds to ace2 as well, and that this makes it harder for the virus to do so alongside it. Nicotine may also soothe inflammation caused by the infection, a hypothesis supported by its use to treat inflamed bowels.

The new French study, which is expected to begin in three weeks’ time, may cast light, too, on another possible therapeutic effect of nicotine. Those severely ill with covid-19 are often the victims of a hyperactive immune response called a cytokine storm [.....]

Why Are Some Young, Healthy People Getting Severe COVID-19?

By Kaleigh Rogers @ FiveThirtyEigh.com, April 23

Summary: they don't know could be many reasons, but are working on it, various studies, all very interesting, especially this part which is also interesting for those who consider antibody testing to indicate safe immune status...could depend on what kind of antibodies...mild exposure might make things worse!?

[....] There’s also a chance that whether or not you have already been exposed to COVID-19 can determine how severe your infection is. With the dengue virus, for example, the first time someone is exposed to the virus, they often have only a mild infection, but if they encounter it a second time, it can become deadly. Researchers believe this is due to the antibodies the body creates after first exposure, which start to diminish over time. If they drop to a low enough level, they’re not able to fight off the virus, but instead they inadvertently assist the virus in infecting cells. It’s called antibody-dependent enhancement, and researchers are investigating whether past exposure to this or a similar coronavirus could worsen the symptoms of COVID-19 [....]